IL18 and type 2 diabetes mellitus: Cognitive impairment in T2DM: Preclinical study showed that liraglutide can reduce the secretion of IL-1β, IL-18, and TNF-α, and reduces neuroinflammation by influencing astrocyte behavior (149)